Relationship between genetic mutations and the incidence of breast câncer: bibliographical review
DOI:
https://doi.org/10.33448/rsd-v12i1.39304Keywords:
Breast cancer; Genetic mutations; Literature review; Incidence.Abstract
Breast cancer is one of the most common types of cancer in the female population and its appearance is related to several factors, with genetic factors, related to mutations in genes, the most studied and with the greatest evidence in carcinogenesis. The discovery of mutations in genes that can lead to a higher incidence of this type of cancer was extremely important for the screening and early diagnosis of this type of tumor. Thus, this article aimed to carry out a bibliographical review of the current literature, from the last 5 years, with the purpose of answering the question “What is the influence of genetic factors on the development of breast cancer?”. For this, databases (BVS, SciELO, PubMed, EbscoHost and Google Scholar) were used. After the search, 22 articles met the inclusion requirements. The existence of mutations in specific genes such as BRCA1 and BRCA2, which are attributed to greater chances of developing this type of neoplasm, was verified. However, genetic mutations in other types of genes, such as TP53 and PALB2, will also be related to a higher incidence of breast cancer in people who carry these types of mutations. It was analyzed that the existence of these mutations, in specific genes, in women and in men, increases the incidence of prostate cancer and breast cancer, both female and male. It was found that greater investment in genomic studies is needed to universalize access to more specific technologies for cancer diagnosis and treatment.
References
Aganezov, S., Goodwin, S., Sherman, R. M., Sedlazeck, F. J., Arun, G., Bhatia, S., & Schatz, M. C. (2020). Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. Genome research, 30(9), 1258-1273.
Beesley, J., Sivakumaran, H., Marjaneh, M. M., Shi, W., Hillman, K. M., Kaufmann, S., & French, J. D. (2020). eQTL colocalization analyses identify NTN4 as a candidate breast cancer risk gene. The American Journal of Human Genetics, 107(4), 778-787.
Bisgin, A., Boga, I., Yalav, O., Sonmezler, O., & Tug Bozdogan, S. (2019). BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history. The Breast Journal, 25(5), 1029-1033.
Breast Cancer Association Consortium. (2021). Breast cancer risk genes—association analysis in more than 113,000 women. New England Journal of Medicine, 384(5), 428-439.
Buranello, M. C., Walsh, I. A. P. D., Pereira, G. D. A., & Castro, S. S. D. (2021). Histórico familiar para câncer de mama em mulheres: estudo populacional em Uberaba (MG) utilizando o Family History Screen-7. Saúde em Debate, 45, 681-690.
Calip, G. S., Kidd, J., Bernhisel, R., Cox, H. C., Saam, J., Rauscher, G. H., & Hoskins, K. F. (2021). Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling. Breast cancer research and treatment, 185(1), 195-204.
Caputo, S. M., Golmard, L., Léone, M., Damiola, F., Guillaud-Bataille, M., Revillion, F., & Viellard, N. (2021). Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach. The American Journal of Human Genetics, 108(10), 1907-1923.
Coelho, A. S., Santos, M. A. D. S., Caetano, R. I., Piovesan, C. F., Fiuza, L. A., Machado, R. L. D., & Furini, A. A. D. C. (2018). Predisposição hereditária ao câncer de mama e sua relação com os genes BRCA1 e BRCA2: revisão da literatura. Rbac, 50(1), 17-21.
Engel, C., Rhiem, K., Hahnen, E., Loibl, S., Weber, K. E., Seiler, S., & Schmutzler, R. K. (2018). Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history. Bmc Cancer, 18(1), 1-6.
Germano, A. B. D. S. B. (2020). Aspectos genéticos relacionados ao câncer de mama. Dissertação de Graduação em Biomedicina, Faculdade de Ciências da Educação e Saúde, Brasília.
Hauke, J., Horvath, J., Groß, E., Gehrig, A., Honisch, E., Hackmann, K., & Hahnen, E. (2018). Gene panel testing of 5589 BRCA 1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer medicine, 7(4), 1349-1358.
Ho, P. J., Ho, W. K., Khng, A. J., Yeoh, Y. S., Tan, B. K. T., Tan, E. Y., ... & Hartman, M. (2022). Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification. BMC medicine, 20(1), 1-11.
Hu, C., Hart, S. N., Gnanaolivu, R., Huang, H., Lee, K. Y., Na, J., & Couch, F. J. (2021). A population-based study of genes previously implicated in breast cancer. New England Journal of Medicine, 384(5), 440-451.
INCA (Instituto Nacional de Câncer José Alencar Gomes da Silva). Estimativa 2020: incidência do Câncer no Brasil. Rio de Janeiro: INCA, 2019. Acesso em:15/10/2022. https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//.
INCA (Instituto Nacional de Câncer José Alencar Gomes da Silva). Dados e números sobre câncer de mama. Relatório anual 2022. INCA, 2022. Acesso em: 15/10/2022. https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//dados_e_numeros_site_cancer_mama_setembro2022.pdf.
Liaw, Y. Y., Loong, F. S., Tan, S., On, S. Y., Khaw, E., Chiew, Y., & Gandhi, A. (2020). A retrospective study on breast cancer presentation, risk factors, and protective factors in patients with a positive family history of breast cancer. The breast journal, 26(3), 469-473.
Manchanda, R., Patel, S., Gordeev, V. S., Antoniou, A. C., Smith, S., Lee, A., & Legood, R. (2018). Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. JNCI: Journal of the National Cancer Institute, 110(7), 714-725.
Matos, S. E. M., Rabelo, M. R. G., & E PEIXOTO, M. C. (2021). Análise epidemiológica do câncer de mama no Brasil: 2015 a 2020/Epidemiological analysis of breast cancer in Brazil: 2015 to 2020. Brazilian Journal of Health Review,[S. l.], 4(3), 13320-13330.
Naeem, M., Hayat, M., Qamar, S. A., Mehmood, T., Munir, A., Ahmad, G., & Hussain, A. (2019). Risk factors, genetic mutations and prevention of breast cancer. Int. J. Biosci, 14(4), 492-496.
Oliveira, A.L.R., Michelini, F.S., Spada, F.C., Pires, K.G., Costa, L.O., Figueiredo, S.B.C., Lemos, A.P. (2020). Fatores de risco e prevenção do câncer de mama. Revista Cadernos de Medicina. 2(3), 135-145.
OMS (Organização Mundial da Saúde). Câncer. 2018. Acesso em: 15/10/2022. https://www.who.int/news-room/fact-sheets/detail/cancer.
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & McKenzie, J. E. (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. bmj, 372.
Palmer, J. R., Polley, E. C., Hu, C., John, E. M., Haiman, C., Hart, S. N., & Couch, F. J. (2020). Contribution of germline predisposition gene mutations to breast cancer risk in African American women. JNCI: Journal of the National Cancer Institute, 112(12), 1213-1221.
Palmero, E. I., Carraro, D. M., Alemar, B., Moreira, M. A. M., Ribeiro-dos-Santos, Â., Abe-Sandes, K., & Ashton-Prolla, P. (2018). The germline mutational landscape of BRCA1 and BRCA2 in Brazil. Scientific reports, 8(1), 1-10.
Pereira, T. L.,Lima, E.V., Cardoso, P.B., Destro, L.R.S., Mattos, G.Z., Esteves, A.P.V.S. (2019). Mutação nos genes BRCA 1 e 2 e os riscos para câncer de mama. Revista Cadernos da Medicina-UNIFESO, 2(2).
Ren, Z. J., Cao, D. H., Zhang, Q., Ren, P. W., Liu, L. R., Wei, Q., & Dong, Q. (2019). First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis. BMC cancer, 19(1), 1-13.
Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007). The PICO strategy for the research question construction and evidence search. Revista Latino-Americana de Enfermagem, 15(3), 508–511.
Sporikova, Z., Koudelakova, V., Trojanec, R., & Hajduch, M. (2018). Genetic markers in triple-negative breast cancer. Clinical breast cancer, 18(5), e841-e850.
Vargas, E., de Deugd, R., Villegas, V. E., Gil, F., Mora, L., Viaña, L. F., & Torres, D. (2022). Prevalence of BRCA1 and BRCA2 Germline Mutations in Patients of African Descent with Early-Onset and Familial Colombian Breast Cancer. The oncologist, 27(2), e151-e157.
Wendt, C., & Margolin, S. (2019). Identifying breast cancer susceptibility genes–a review of the genetic background in familial breast cancer. Acta Oncologica, 58(2), 135-146.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ana Flávia Queiroz Miquelanti; Bethânia Cristhine de Araújo; Natália de Fátima Gonçalves Amâncio
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
